Jason Kolbert

Mar 25, 2026

Jason Kolbert rated NRSN as Buy on Mar 25, 2026, setting a price target of 14. Shares have remained stable near 0.77, leaving the 14 target still in play.

Mar 25, 2026

On Mar 25, 2026, BMEA was given a Buy rating by Jason Kolbert, with a target price of 12. The stock traded sideways with a 0.00% move, keeping the bullish thesis unresolved.

Mar 25, 2026

HOTH received a Buy rating from Jason Kolbert on Mar 25, 2026, aiming for 5. Price action was muted, as shares hovered around 0.8987 despite the bullish outlook.

Mar 24, 2026

On Mar 24, 2026, Jason Kolbert published a Buy outlook on EVTL, with a target of 12. Market action contradicted the Buy thesis, as shares slipped to 2.65.

Mar 24, 2026

Jason Kolbert on Mar 24, 2026 assigned CNTX a Buy rating, with a price target of 9. The call has struggled to gain traction, with shares losing 16.04%.

Mar 24, 2026

On Mar 24, 2026, Jason Kolbert reaffirmed TTRX with a Buy rating, targeting 8. Market indecision has kept the 8 target in a holding pattern.

Mar 24, 2026

NRXP was rated Buy by Jason Kolbert on Mar 24, 2026, with a price objective of 34. A bullish response from the market helped close the gap of 31.59 to the target.

Mar 23, 2026

On Mar 23, 2026, Jason Kolbert initiated coverage on FATN with a Buy rating and target of 8. The Buy call has yet to be validated as shares remain 6.27 away from the target.

Mar 23, 2026

Jason Kolbert issued a Buy recommendation for IBRX on Mar 23, 2026, price target set at 23. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Mar 23, 2026

On Mar 23, 2026, AVXL was evaluated by Jason Kolbert, who gave a Buy rating and target of 24. Investors saw limited payoff as shares fell short of the 24 target.

Mar 19, 2026

Jason Kolbert rated CRVO as Buy on Mar 19, 2026, setting a price target of 31. Shares have remained stable near 4.04, leaving the 31 target still in play.

Mar 19, 2026

On Mar 19, 2026, PSTV was given a Buy rating by Jason Kolbert, with a target price of 3. The stock traded sideways with a 1.99% move, keeping the bullish thesis unresolved.

Mar 19, 2026

MDCX received a Buy rating from Jason Kolbert on Mar 19, 2026, aiming for 27. Price action was muted, as shares hovered around 0.4939 despite the bullish outlook.

Mar 19, 2026

On Mar 19, 2026, Jason Kolbert published a Buy outlook on HUMA, with a target of 25. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 0.823.

Mar 19, 2026

Jason Kolbert on Mar 19, 2026 assigned COYA a Buy rating, with a price target of 15. The recommendation remains pending validation as shares consolidate around 4.195.

Mar 18, 2026

On Mar 18, 2026, Jason Kolbert reaffirmed TRVI with a Buy rating, targeting 19. The recommendation was supported by strong follow-through as the stock rose from 11.44 to 11.44.

Mar 18, 2026

VNRX was rated Buy by Jason Kolbert on Mar 18, 2026, with a price objective of 3. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Mar 18, 2026

On Mar 18, 2026, Jason Kolbert initiated coverage on XAIR with a Buy rating and target of 10. The Buy call has yet to be validated as shares remain 9.26 away from the target.

Mar 17, 2026

Jason Kolbert issued a Buy recommendation for VERI on Mar 17, 2026, price target set at 23. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Mar 12, 2026

On Mar 12, 2026, CLNN was evaluated by Jason Kolbert, who gave a Buy rating and target of 23. Investors saw limited payoff as shares fell short of the 23 target.

Mar 12, 2026

Jason Kolbert rated FBLG as Buy on Mar 12, 2026, setting a price target of 7. The stock has underperformed, dropping 22.52% despite the bullish target of 7.

Mar 11, 2026

On Mar 11, 2026, CTXR was given a Buy rating by Jason Kolbert, with a target price of 6. Despite the Buy call, shares fell from 0.72 to 0.72, challenging the optimistic stance.

Mar 09, 2026

ADUR received a Buy rating from Jason Kolbert on Mar 09, 2026, aiming for 46. Price action was muted, as shares hovered around 10.83 despite the bullish outlook.

Mar 09, 2026

On Mar 09, 2026, Jason Kolbert published a Buy outlook on OSTX, with a target of 20. Market action contradicted the Buy thesis, as shares slipped to 1.44.

Mar 06, 2026

Jason Kolbert on Mar 06, 2026 assigned LCTX a Buy rating, with a price target of 3. The call has struggled to gain traction, with shares losing 16.22%.

Mar 05, 2026

LUNG was rated Buy by Jason Kolbert on Mar 05, 2026, with a price objective of 14. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

Mar 03, 2026

On Mar 03, 2026, NNOX was evaluated by Jason Kolbert, who gave a Buy rating and target of 5. Investors saw limited payoff as shares fell short of the 5 target.

Mar 02, 2026

Jason Kolbert rated URGN as Buy on Mar 02, 2026, setting a price target of 33. Shares have remained stable near 18.12, leaving the 33 target still in play.

Feb 17, 2026

RCEL received a Buy rating from Jason Kolbert on Feb 17, 2026, aiming for 10. The rating hasn’t played out as hoped, with the stock trading 7.42% below expectations.

Feb 13, 2026

On Feb 13, 2026, Jason Kolbert published a Buy outlook on IMUX, with a target of 8. Shares gained 44.66%, underscoring the accuracy of the bullish outlook toward 8.

Feb 11, 2026

Jason Kolbert on Feb 11, 2026 assigned HOVR a Buy rating, with a price target of 11. The call has struggled to gain traction, with shares losing 18.89%.

Feb 11, 2026

On Feb 11, 2026, Jason Kolbert reaffirmed CRMD with a Buy rating, targeting 14. Shares slid 11.04% despite the recommendation, highlighting downside risks.

Feb 09, 2026

ESLA was rated Buy by Jason Kolbert on Feb 09, 2026, with a price objective of 8. This case shows how bullish projections can fail, with the stock now below 0.9802.

Feb 04, 2026

Jason Kolbert issued a Buy recommendation for ANIX on Feb 04, 2026, price target set at 10. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Jan 30, 2026

Jason Kolbert rated MNOV as Buy on Jan 30, 2026, setting a price target of 9. The stock has underperformed, dropping 15.12% despite the bullish target of 9.

Jan 27, 2026

On Jan 27, 2026, OMER was given a Buy rating by Jason Kolbert, with a target price of 36. Despite the Buy call, shares fell from 10.44 to 10.44, challenging the optimistic stance.

Jan 12, 2026

CTSO received a Buy rating from Jason Kolbert on Jan 12, 2026, aiming for 10. Price action was muted, as shares hovered around 0.6713 despite the bullish outlook.

Jan 06, 2026

On Jan 06, 2026, Jason Kolbert published a Buy outlook on CMPX, with a target of 30. Shares gained 11.81%, underscoring the accuracy of the bullish outlook toward 30.

Dec 17, 2025

Jason Kolbert on Dec 17, 2025 assigned CANF a Buy rating, with a price target of 11. The call has struggled to gain traction, with shares losing 97.05%.

Dec 04, 2025

On Dec 04, 2025, Jason Kolbert reaffirmed PAPL with a Buy rating, targeting 5. Shares slid 82.01% despite the recommendation, highlighting downside risks.

Dec 01, 2025

AREC was rated Buy by Jason Kolbert on Dec 01, 2025, with a price objective of 6. This case shows how bullish projections can fail, with the stock now below 2.54.

Nov 19, 2025

On Nov 19, 2025, KAPA was evaluated by Jason Kolbert, who gave a Buy rating and target of 9. Investors saw limited payoff as shares fell short of the 9 target.

Oct 28, 2025

On Oct 28, 2025, CODX was given a Buy rating by Jason Kolbert, with a target price of 3. The stock rallied 245.61% after the rating, narrowing the gap to the target of 3 and validating the bullish stance.

Oct 17, 2025

MSAI received a Buy rating from Jason Kolbert on Oct 17, 2025, aiming for 3. The rating hasn’t played out as hoped, with the stock trading 53.08% below expectations.

Aug 08, 2025

Jason Kolbert on Aug 08, 2025 assigned CARM a Buy rating, with a price target of 1. The call has struggled to gain traction, with shares losing 87.74%.

Apr 02, 2025

On Apr 02, 2025, Jason Kolbert reaffirmed SCLX with a Buy rating, targeting 18. Shares slid 35.47% despite the recommendation, highlighting downside risks.

Mar 31, 2025

CKPT was rated Buy by Jason Kolbert on Mar 31, 2025, with a price objective of 4.8. A bullish response from the market helped close the gap of 0.54 to the target.

Mar 24, 2025

On Mar 24, 2025, Jason Kolbert initiated coverage on IMNN with a Buy rating and target of 29. The Buy call has yet to be validated as shares remain 26.22 away from the target.

Nov 13, 2024

On Nov 13, 2024, MRNS was evaluated by Jason Kolbert, who gave a Buy rating and target of 3. This case illustrates how a timely bullish rating can translate into tangible gains of 81.94%.

Sep 24, 2024

Jason Kolbert rated LUMO as Buy on Sep 24, 2024, setting a price target of 16. The call has proven timely, with shares rising 10.71% toward the price target of 16.